Skip to main content
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. logo

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. — Investor Relations & Filings

Ticker · GENIL ISIN · TREGENL00016 LEI · 789000A4NW6W4D8Z4H25 IS Manufacturing
Open in API
Filings indexed 675 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country TR Türkiye
Listing IS GENIL

About GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

https://www.genilac.com.tr

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. is a specialty pharmaceutical company established in 1998 that provides solutions for rare diseases and unmet medical needs. The company operates a GMP-certified manufacturing facility and an R&D center to develop, produce, and supply a wide range of products for international markets. Its business model combines strategic partnerships with global firms and in-house innovation to address complex health challenges, leveraging over 25 years of experience in its specialized therapeutic areas.

Recent filings

Filing Released Lang Actions
Signature of New Distributorship Agreement
Regulatory Filings
2026-05-04 Turkish
Update About Solar Power Plant Project
Regulatory Filings
2026-05-04 Turkish
Interview of the our Company's Chairman of The Board of Directors Mr. Abidin GÜLMÜŞ
Regulatory Filings Classification · 1% confidence The document is a Turkish BIST-style “Özel Durum Açıklaması (Genel)” (Material Event Disclosure General) providing highlights of an interview by the Chairman, with no detailed financial statements or substantive report content. It is a mandated public disclosure of a material event rather than a full report, earnings release or other specialized filing. Therefore, it is best classified as a general regulatory announcement (RNS).
2026-04-29 Turkish
Signing of an Alternative Reimbursement Agreement regarding the Supply of VOXZOGO
Regulatory Filings Classification · 1% confidence The document is a Material Event Disclosure (“Özel Durum Açıklaması”) announcing that Gen İlaç signed an Alternative Reimbursement Agreement with the Social Security Institution for drug supply. It is not a financial report (10-K, IR, ER), management change, dividend notice, share transaction, or any specific category like M&A or financing. It is a general regulatory announcement of a material contract, so the appropriate classification is the fallback “Regulatory Filings” (RNS).
2026-04-27 Turkish
Company General Info Form
Governance Information Classification · 1% confidence The document is a straightforward listing of the company’s top management team, their titles, professions, and positions held. It does not announce any changes (appointments/resignations), nor is it part of an earnings or operational report. Instead, it provides governance-related information about the board and senior management structure, which fits the definition of a Governance Information (CGR) filing.
2026-04-22 English
Genel Kurul Tescili
AGM Information Classification · 1% confidence The document is the full minutes (‘tutanak’) of the 2025 Ordinary General Assembly Meeting (Olağan Genel Kurul) held on 31.03.2026, detailing call to meeting, quorum, elections, vote results on agenda items (approval of reports, election of board members, dividend resolution, etc.). It is not an earnings release or financial report itself but the formal record of the AGM proceedings. This aligns with the AGM Information category, which covers presentations and materials shared (including minutes) during the Annual General Meeting. Therefore, it should be classified as AGM-R.
2026-04-03 Turkish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.